Status:
UNKNOWN
Chronotherapy for Radiotherapy of Glioma
Lead Sponsor:
General Hospital of Ningxia Medical University
Conditions:
To Determine Whether the Timing of Radiotherapy Has an Effect on Patient Outcomes
Eligibility:
All Genders
18-80 years
Brief Summary
This study aims to determine if there is any difference in the efficacy of radiotherapy for glioma outcomes in the morning or in the evening. The study team believes that there may be a benefit to tak...
Detailed Description
The objective of this study is to determine whether the timing of radiotherapy to treat glioma has an effect on patient outcomes. Primary objective: Determine whether there is a difference in outcome...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Pathological or cytological diagnosis of glioma;
- Normal liver and kidney function.
Exclusion
- Pregnant or lactating women;
- Second primary malignancy;
- Severe lung infection;
- with high blood pressure although treated with medication;
- Patients with myocardial ischemia or myocardial infarction, arrhythmia (including QT interval \> 440 ms) or grade II cardiac insufficiency;
- Arteriovenous thrombosis in 6 months prior to first administration, Such as cerebrovascular accident (including temporary ischemic attack), deep vein thrombosis and pulmonary embolism;
- Serious heart, lung and bone marrow impairment;
- History of severe hypertension or cerebral hemorrhage
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04735939
Start Date
February 1 2021
End Date
December 31 2021
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China, 750004